Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 231
Selected: 0
NCT IDTitle
NCT06954246A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT05309629Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer
NCT04234594Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
NCT01946919Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
NCT06644495Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib
NCT06994507GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
NCT07040228A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer
NCT07272590Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors
NCT03169335Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer
NCT07040826Lifitegrast Eye Drops in Healthy Subjects:Phase I Study
NCT06446310Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
NCT05758519A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19
NCT07258394Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
NCT07487103Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes
NCT05803642A Study of Olanzapine in Patients With Acute Agitation
NCT03312283Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD
NCT07560449QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms
NCT07489599A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
NCT07441317QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)
NCT05920876A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma
NCT07138209A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT04864782QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
NCT05950516Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
NCT05554913Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia
NCT07511647A Phase 3 Clinical Study of QL2106 Injection
NCT05461287Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors
NCT05799820QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC
NCT05830045A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors
NCT05922436a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency
NCT05055687Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)
NCT07302516Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma
NCT06884891A Phase Ⅲ Comparative Study of QL2108 to Dupixent®
NCT07667751An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer
NCT04641754A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer
NCT01931943A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer
NCT07400744A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects
NCT05802342A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer
NCT06799559Study on the Efficacy and Safety of QLM1016 in Schizophrenia
NCT05060419Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections
NCT06151587A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children
NCT04326829QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors
NCT06019013A Study of QLF3108 in Participants With Advanced Solid Tumor
NCT06742216Monosialoganglioside in Acute Ischemic Stroke: a Randomized, Blinded and Multicenter Confirmatory Study
NCT07358858A Food Effect Study of QLS1410 in Healthy Chinese Adults
NCT05629949A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer
NCT05446883QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
NCT07463573QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT07256782A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
NCT06864793Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers
NCT03267654Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance